Skip to main content
OpenTrials

Clinical trial condition

Relapsing-Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing-Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

97 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Relapsing-Remitting Multiple Sclerosis trial results

Completed

Extension Study of MT-1303

NCT01890655

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site City Name, Belgium
  • Research Site City Name, Bulgaria
  • Research Site City Name, Canada
  • Research Site City Name, Croatia
View all 17 locations
View Trial Details
Completed

Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT01416155

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Chiba, Japan
  • Research Site Fukuoka, Japan
  • Research Site Hiroshima, Japan
  • Research Site Sapporo, Hokkaido, Japan
View all 22 locations
View Trial Details
Completed

Safety and Tolerability of Glatiramer Acetate

NCT01874145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Teva Investigational Site 10706 Cullman, Alabama, United States
  • Teva Investigational Site 10719 Gilbert, Arizona, United States
  • Teva Investigational Site 10720 Phoenix, Arizona, United States
  • Teva Investigational Site 10727 Fresno, California, United States
View all 35 locations
View Trial Details
Completed

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)

NCT01405820

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Brasschaat, Belgium
  • Research Site Liège, Belgium
  • Research Site Overpelt, Belgium
  • Research Site Wilrijk, Belgium
View all 64 locations
View Trial Details
Completed

Mass Balance Study of MT-1303

NCT02293967

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Investigational site Ruddington, Nottingham, United Kingdom
View Trial Details

Related conditions